Alternative funding: Disease foundations, govt sources promote available capital
This article was originally published in Scrip
Executive Summary
Eager to help firms access capital while government funding is squeezed and venture capitalists are backing away from early-stage technology - and even Big Pharma are cutting research programs - alternative sources of capital are reaching out to the drug development industry.